Muscle Therapy With Arnica

Arnica Montana, Bellis Perennis, Hypericum Perforatum, Ledum Palustre Twig, And Ruta Graveolens Flowering Top


Hyland's Inc.
Human Otc Drug
NDC 54973-3085
Muscle Therapy With Arnica also known as Arnica Montana, Bellis Perennis, Hypericum Perforatum, Ledum Palustre Twig, And Ruta Graveolens Flowering Top is a human otc drug labeled by 'Hyland's Inc.'. National Drug Code (NDC) number for Muscle Therapy With Arnica is 54973-3085. This drug is available in dosage form of Gel. The names of the active, medicinal ingredients in Muscle Therapy With Arnica drug includes Arnica Montana - 2 [hp_X]/g Bellis Perennis - 3 [hp_X]/g Hypericum Perforatum - 3 [hp_X]/g Ledum Palustre Twig - 3 [hp_X]/g Ruta Graveolens Flowering Top - 3 [hp_X]/g . The currest status of Muscle Therapy With Arnica drug is Active.

Drug Information:

Drug NDC: 54973-3085
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Muscle Therapy With Arnica
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Arnica Montana, Bellis Perennis, Hypericum Perforatum, Ledum Palustre Twig, And Ruta Graveolens Flowering Top
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Hyland's Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Gel
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ARNICA MONTANA - 2 [hp_X]/g
BELLIS PERENNIS - 3 [hp_X]/g
HYPERICUM PERFORATUM - 3 [hp_X]/g
LEDUM PALUSTRE TWIG - 3 [hp_X]/g
RUTA GRAVEOLENS FLOWERING TOP - 3 [hp_X]/g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 15 Jan, 2009
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 07 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Hyland's Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:O80TY208ZW
2HU33I03UY
XK4IUX8MNB
877L01IZ0P
N94C2U587S
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
54973-3085-11 TUBE in 1 CARTON (54973-3085-1) / 85 g in 1 TUBE15 Jan, 2009N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Temporarily relieves the symptoms of muscle pain, soreness, bruising and swelling due to overexertion or injury.

Product Elements:

Muscle therapy with arnica arnica montana, bellis perennis, hypericum perforatum, ledum palustre twig, and ruta graveolens flowering top chondrus crispus hydroxyethyl cellulose (5000 mpa.s at 1%) potassium sorbate water alcohol sodium benzoate arnica montana arnica montana bellis perennis bellis perennis hypericum perforatum hypericum perforatum ledum palustre twig ledum palustre twig ruta graveolens flowering top ruta graveolens flowering top light brown

Indications and Usage:

Uses temporarily relieves the symptoms of muscle pain, soreness, bruising and swelling due to overexertion or injury.

Warnings:

Warnings for external use only. do not use on open wounds. as with any drug, ask a doctor before use if pregnant or nursing a baby. consult a physician if symptoms persist for more than 7 days or worsen. keep this and all medications out of the reach of children. in case of accidental overdose, contact a medical professional or a poison control center immediately. do not use if tube seal is broken or missing. in case of emergency, contact a medical professional or poison control center immediately. hyland's may also be contacted for emergency information about our products 24 hours a day, 7 days per week at 1-800-624-9659.

Dosage and Administration:

Directions adults and children 6 years and over: apply as needed to affected area 3 times daily until relieved. may be applied directly before strenuos activity or injury.

Package Label Principal Display Panel:

Principal display panel - 85g tube carton speeds recovery ndc 54973-3085-1 hyland's ® homeopathic since 1903 natural pain relief muscle therapy™ gel with arnica bruising stiffness swelling joint and muscle soreness advance defense pain relief formula 3oz 85g made in usa carton


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.